Simply blot the area gently with a cotton ball or gauze
Recent research indicates that while these drugs significantly reduce body weight and adiposity, fat-free mass lost accounts for 25-40% of the total weight lost during therapy, raising concerns about muscle loss, which is vital for overall health and physical function
In addition to considering inflators that increase costs and deflators that can reduce spending, PwC suggests we also consider some trends that could move this needle up or down, such as CMS price transparency, the implementation of GenAI, prospects for Medicaid, the impact of the No Surprises Act of 2022 (on in-network vs out-of-network utilization think ERs and radiology, for prime examples), and implications of the Inflation Reduction Act (IRA) especially on prescription drug pricing
Potential limited roles include: Severe illness Hospitalized patients Select immunocompromised individuals Carefully selected outbreak scenarios Even then, expectations should remain realistic
